Bloomingdale’s And Clarins Launch Here Comes The Sun Program To Support Skin Cancer Research At John Wayne Cancer Institute At Saint John’s Health Center
MAY IS MELANOMA AWARENESS MONTH
SANTA MONICA, Calif., May 2, 2013 /PRNewswire/ — Southern California Bloomingdale’s and Clarins announces the Here Comes The Sun program to support skin cancer research at the John Wayne Cancer Institute (JWCI) at Saint John’s Health Center in Santa Monica in honor of Melanoma Awareness Month.
Bloomingdale’s Santa Monica, Beverly Center, Century City, Sherman Oaks, Newport Beach, South Coast Plaza (Costa Mesa) and Fashion Valley (San Diego) will donate 5% of sales from the purchase of the following Clarins products from May 1 through May 31 to support the cutting edge skin cancer research taking place at John Wayne Cancer Institute:
- Extra Firming Day Wrinkle Lifting Cream
- Extra Firming Night Rejuvenating Cream
- Beauty Flash Balm
- UV Plus HP SPF 40 Day Screen
- UV Plus HP SPF 40 Day Screen Tint-light, medium, dark
“Melanoma is the most common and deadly form of skin cancer in the United States,” said Delphine Lee, MD, PhD, FAAD, Dermatologist and Immunologist Director, Translational Immunology, Dirks/Dougherty Laboratory for Cancer Research at JWCI. “With the number of people diagnosed with melanoma on the rise, we need to educate people on how to minimize their risk of skin cancer.”
Dr. Lee will be on hand at Bloomingdale’s Santa Monica on May 18 at 1:00 pm to offer preventive skin cancer tips, what to look for in detecting potential cancers including the ABCDE rule: Asymmetry, Border, Color, Diameter and Evolution of spots or lesions on the body.
Since 1981, the John Wayne name has been committed by the Wayne family to groundbreaking cancer research and education in memory of their father, who died of cancer. For more than 30 years, the dedicated researchers at the John Wayne Cancer Institute have changed the way the world approaches cancer research and treatment yielding new breakthroughs that have helped doctors detect cancer sooner, stage it more precisely and treat it more effectively. Today, the Institute is advancing its world renowned programs in melanoma, breast, neuro and gastrointestinal cancers. With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, the Institute provides immediate hope to cancer patients around the globe. For information, visit www.jwci.org.
SOURCE John Wayne Cancer Institute